Royalty Pharma plc Quarterly Interest Expense in USD from Q2 2019 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Royalty Pharma plc quarterly/annual Interest Expense history and growth rate from Q2 2019 to Q1 2024.
  • Royalty Pharma plc Interest Expense for the quarter ending March 31, 2024 was $44.2M, a 5.79% decline year-over-year.
  • Royalty Pharma plc Interest Expense for the twelve months ending March 31, 2024 was $184M, a 1.8% decline year-over-year.
  • Royalty Pharma plc annual Interest Expense for 2023 was $187M, a 0.41% decline from 2022.
  • Royalty Pharma plc annual Interest Expense for 2022 was $188M, a 13.1% increase from 2021.
  • Royalty Pharma plc annual Interest Expense for 2021 was $166M, a 5.78% increase from 2020.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $184M $44.2M -$2.72M -5.79% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $187M $47.3M +$300K +0.64% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-15
Q3 2023 $187M $46M -$944K -2.01% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-08
Q2 2023 $188M $46.9M -$17K -0.04% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-08
Q1 2023 $188M $47M -$113K -0.24% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 $188M $47M -$19K -0.04% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-15
Q3 2022 $188M $47M +$2.65M +5.98% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-08
Q2 2022 $185M $47M +$9.54M +25.5% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 $176M $47.1M +$9.65M +25.8% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 $166M $47M +$9.13M +24.1% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-15
Q3 2021 $157M $44.3M +$12.9M +41% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 $144M $37.4M +$3.24M +9.47% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 $141M $37.4M -$16.2M -30.2% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q4 2020 $157M $37.8M Oct 1, 2020 Dec 31, 2020 10-K 2023-02-15
Q3 2020 $31.4M -$37.4M -54.3% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 $34.2M -$35M -50.6% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-11
Q1 2020 $53.6M Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-11
Q3 2019 $68.8M Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-12
Q2 2019 $69.2M Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.